SCHEDULE 13G: RTW Investments and Dr. Roderick Wong Disclose 8.3% Stake in COMPASS Pathways plc

RTW Investments, LP and its Managing Partner, Roderick Wong, M.D., have disclosed a beneficial ownership of 8.3% in COMPASS Pathways plc, including shares from exercisable warrants.

Summary

• RTW Investments, LP and Roderick Wong, M.D. (collectively, the "Reporting Persons") have filed a Schedule 13G, disclosing their beneficial ownership in COMPASS Pathways plc.
• As of March 31, 2025, the Reporting Persons beneficially own an aggregate of 7,877,349 Ordinary Shares of COMPASS Pathways plc.
• This ownership represents 8.3% of the outstanding Ordinary Shares of COMPASS Pathways plc.
• The reported amount includes warrants held by the Reporting Persons to purchase 2,339,181 Shares.
• The percentage of class is calculated based on 92,849,501 Shares outstanding as of April 14, 2025, as reported in the Company's Preliminary Proxy Statement on Schedule 14A filed on April 16, 2025, and assumes the exercise of the aforementioned warrants.
• The Reporting Persons have shared voting and dispositive power over all 7,877,349 shares.
• The acquisition of these securities was made in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the company's performance. The disclosure of a significant stake by an institutional investor could be viewed as a neutral to slightly positive signal of investor confidence.

Positives

• A significant institutional investor, RTW Investments, LP, and its key principal, Roderick Wong, M.D., have disclosed a substantial 8.3% stake, indicating confidence in COMPASS Pathways plc.
• The holding includes a significant number of warrants (2,339,181 Shares), suggesting a long-term investment perspective and potential for increased ownership.

Negatives

• The document does not contain any negative financial or operational information, as it is a beneficial ownership disclosure.

Risks

• The Reporting Persons cannot exercise any of the warrants to the extent that such exercise would result in beneficial ownership exceeding 9.99% of the outstanding shares, which could limit their ability to increase their stake beyond this threshold through warrant exercise.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction, as it is a beneficial ownership disclosure.

Industry Context

This filing indicates a significant investment by a specialized healthcare investment firm in COMPASS Pathways plc, a company focused on mental health care, particularly psychedelic-assisted therapies. Such investments by dedicated funds can signal confidence in the long-term potential of the company and the broader psychedelic medicine industry, which is an emerging and evolving sector within healthcare.

Comparison to Industry Standards

• NA This document is a beneficial ownership disclosure (Schedule 13G) and does not contain financial results or operational performance data that would allow for direct comparison to industry standards or specific comparable companies/projects. It solely reports on the ownership stake of an institutional investor.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by RTW Investments, LP and Roderick Wong, M.D., may be viewed positively by other shareholders as it indicates institutional confidence and a substantial long-term investment in the company.
• Company Management: Awareness of a large, active institutional investor like RTW Investments may influence management's strategic decisions and communication, as such investors often engage with companies on governance and strategy.

Key Dates

Keywords

COMPASS Pathways plc, RTW Investments, Roderick Wong, Schedule 13G, Beneficial Ownership, Ordinary Shares, Warrants, Institutional Investor, Biotechnology, Pharmaceutical, Mental Health